Intelligence Platform

Patents

Browse 16 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 11180562

Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-r

CytomX Therapeutics, Inc. · Granted Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11052089

Methods for inhibiting alpha-v beta-3 expression on cancer stem cells and inhibiting progr

The Regents of the University of California · Granted Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9315534

Radiologic agents for monitoring alzheimer's disease progression and Evaluating a Response

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 14 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7053263

Mouse models of human prostate cancer progression

The Regents of the University of California · Granted Tue May 30 2006 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 6956145

Mice models of human prostate cancer progression

The Regents of the University of California · Granted Tue Oct 18 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6949690

Methods of assessing the effect of a gene of interest on human prostate cancer progression

The Regents of the University of California · Granted Tue Sep 27 2005 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6815574

Methods of simulating human prostate cancer progression

The Regents of the University of California · Granted Tue Nov 09 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6790615

Methods and compositions for regulating cell cycle progression

The Regents of the University of California · Granted Tue Sep 14 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6689561

Tumor suppressor gene and methods for detection of cancer, monitoring of tumor progression

The Regents of the University of California · Granted Tue Feb 10 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6673559

Met proto-oncogene and a method for predicting breast cancer progression

The United States of America as Represented by the Government of the Department of Health and Human Services · Granted Tue Jan 06 2004 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6600030

Delayed progression to aids by a missense allele of the CCR2 gene

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 29 2003 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6365797

Mice models of human prostate cancer progression

The Regents of the University of California · Granted Tue Apr 02 2002 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6245752

Compositions and methods for tolerization in immune complex-mediated disease progression

BioCrystal, Ltd. · Granted Tue Jun 12 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6224866

Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors

BioCrystal, Ltd. · Granted Tue May 01 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6183961

Methods and compositions for regulating cell cycle progression

The Regents of the University of California · Granted Tue Feb 06 2001 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6107540

Mice models of human prostate cancer progression

The Regents of the University of California · Granted Tue Aug 22 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired